A useful tool for the initial assessment of blood-brain barrier permeability after traumatic brain injury in rabbits: Dynamic contrast-enhanced magnetic resonance imaging

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 6, 2011, Pages 1645-1650

  Wei, Xiao Er ^a   Wang, Dan ^a   Li, Ming Hua ^a   Zhang, Yu Zhen ^a   Li, Yue Hua ^a   Li, Wen Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Blood"brain barrier; Dynamic contrast enhanced MRI; Rabbit; T2 weighted imaging; Traumatic brain injury

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXPERIMENTAL RABBIT; FORCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRAUMATIC BRAIN INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJURY SEVERITY SCORE; MAGNETIC RESONANCE IMAGING; RABBITS; RADIOGRAPHIC IMAGE ENHANCEMENT; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 84255166719     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31823498eb     Document Type: Article

References (41)

1. Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol. 2010;6:393-403.
2. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol. 2010;226:183-190.
3. Yang FY, Horng SC, Lin YS, Kao YH. Association between contrastenhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J Magn Reson Imaging. 2010;32:593-599.
4. Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology. 2007;68:1809-1814. (Pubitemid 46791393)
5. Wang G, Guo Q, Hossain M, et al. Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Res. 2009; 1294:183-192.
6. Larsson HB, Courivaud F, Rostrup E, Hansen AE. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T (1)-weighted MRI at 3 tesla. Magn Reson Med. 2009;62:1270-1281.
7. Wuerfel E, Infante-Duarte C, Glumm R, Wuerfel JT. Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation. J Neuroinflammation. 2010;7:70.
8. Lemasson B, Serduc R, Maisin C, et al. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of lowmolecular- weight and macromolecular MR contrast media. Radiology. 2010;257:342-352.
9. Türkbey B, Thomasson D, Pang Y, Bernardo M, Choyke PL. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol. 2010;16:186-192.
10. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. Combined dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging. 2008;26:1071-1080.
11. Armitage PA, Farrall AJ, Carpenter TK, Doubal FN, Wardlaw JM. Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn Reson Imaging. 2011;29:305-314.
12. Wang H, Golob EJ, Su MY. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls. J Magn Reson Imaging. 2006;24:695-700. (Pubitemid 44320575)
13. Abo-Ramadan U, Durukan A, Pitkonen M, et al. Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plot. Exp Neurol. 2009;219:328-333.
14. Vidarsson L, Thornhill RE, Liu F, Mikulis DJ, Kassner A. Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan? Magn Reson Imaging. 2009;27:1216-1222.
15. Kharatishvili I, Sierra A, Immonen RJ, Gröhn OH, Pitkänen A. Quantitative T2 mapping as a potential marker for the initial assessment of the severity of damage after traumatic brain injury in rat. Exp Neurol. 2009;217:154-164.
16. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA. 2004;101:5117-5122. (Pubitemid 38469212)
17. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 1981;211:67-77. (Pubitemid 11147211)
18. Laurer HL, McIntosh TK. Experimental models of brain trauma. Curr Opin Neurol. 1999;12:715-721. (Pubitemid 30072353)
19. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17:357-367.
20. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T (1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223-232. (Pubitemid 29463104)
21. Chastain CA, Oyoyo UE, Zipperman M, et al. Predicting outcomes of traumatic brain injury by imaging modality and injury distribution. J Neurotrauma. 2009;26:1183-1196.
22. Lu D, Mahmood A, Qu C, Hong X, Kaplan D, Chopp M. Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery. 2007;61:596-602. (Pubitemid 47442659)
23. Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC; ASAP Investigators. Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke. 2009; 40:2422-2427.
24. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome?: a multivariable analysis. Stroke. 2000;31:2597-2602.
25. Onyszchuk G, Al-Hafez B, He YY, Bilgen M, Berman NE, Brooks WM. A mouse model of sensorimotor controlled cortical impact: characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology. J Neurosci Methods. 2007;160:187-196. (Pubitemid 46241456)
26. Darling WG, Pizzimenti MA, Rotella DL, et al. Volumetric effects of motor cortex injury on recovery of dexterous movements. Exp Neurol. 2009;220:90-108.
27. Adelson PD, Whalen MJ, Kochanek PM, Robichaud P, Carlos TM. Blood brain barrier permeability and acute inflammation in two models of traumatic brain injury in the immature rat: a preliminary report. Acta Neurochir Suppl. 1998;71:104-106. (Pubitemid 128444370)
28. Sharma HS, Patnaik R, Patnaik S, Mohanty S, Sharma A, VannemreddyP. Antibodies to serotonin attenuate closed head injury induced bloodbrain barrier disruption and brain pathology. Ann N Y Acad Sci. 2007; 1122:295-312. (Pubitemid 350249556)
29. Korn A, Golan H, Melamed I, Pascual-Marqui R, Friedman A. Focal cortical dysfunction and blood-brain barrier disruption in patients with Postconcussion syndrome. Clin Neurophysiol. 2005;22:1-9. (Pubitemid 40194694)
30. Lorberboym M, Lampl Y, Sadeh M. Correlation of 99mTc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke. J Nucl Med. 2003;44:1898-1904. (Pubitemid 40022134)
31. Rodríguez-Baeza A, Reina-de la Torre F, Poca A, Martí M, Garnacho A. Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study. Anat Rec ADiscov Mol Cell Evol Biol. 2003;273:583-593. (Pubitemid 37408351)
32. Bartels AL, Willemsen AT, Kortekaas R, et al. Decreased blood-brainbarrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J Neural Transm. 2008;115:1001-1009.
33. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol. 2005;57:176-179. (Pubitemid 40179854)
34. Song SK, Lee SK, Lee JJ, et al. Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy. Neurobiol Aging. 2011;32:2183-2189.
35. Rite I, Machado A, Cano J, Venero JL. Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J Neurochem. 2007;101:1567-1582. (Pubitemid 46848862)
36. Marchi N, Angelov L, Masaryk T, et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia. 2007;48:732-742. (Pubitemid 46587627)
37. Seiffert E, Dreier JP, Ivens S, et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci. 2004;24:7829-7836. (Pubitemid 39215686)
38. Immonen RJ, Kharatishvili I, Gröhn H, Pitkänen A, Gröhn OH. Quantitative MRI predicts long-term structural and functional outcome after experimental traumatic brain injury. Neuroimage. 2009;45:1-9.
39. Oby E, Janigro D. The blood-brain barrier and epilepsy. Epilepsia. 2006;47:1761-1774. (Pubitemid 44730046)
40. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178-201.
41. Tomkins O, Friedman O, Ivens S, et al. Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis. 2007;25:367-377 (Pubitemid 46124017)